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ABSTRACT
Objectives: Collagen type I plays an important role in the bone matrix and is encoded by COL1A2 (collagen type I alpha 2) 
gene that may be a potential candidate for osteoporotic fracture. The aim of this study is to determine whether EcoRI, 
Del38 and PvuII polymorphisms of COL1A2 are associated with the development of osteoporosis and osteopenia in post-
menopausal Polish women. Moreover, analysis of relationship between frequency of COL1A2 gene polymorphic variants 
and clinical parameters of bone turnover and degree of osteoporosis was performed.
Material and methods: The study group comprised of women with osteoporosis (n = 90), osteopenia (n = 56) and healthy 
individuals (n = 56). The EcoRI, Del38 and PvuII polymorphisms in COL1A2 gene were detected by PCR-RFLP method. 
Results: In women with osteoporosis the TT genotype of EcoRI polymorphism had the lowest Z-score value compared to 
other genotypes (p = 0.034). In case of Del28 polymorphism, there was a statistically significant correlation between lower 
BMI values and the DD genotype in women with osteopenia (p = 0.041). There was no statistically significant correlation 
between polymorphic variants of Del28 polymorphism and clinical parameters of women with osteoporosis. The analysis 
of PvuII polymorphism showed that in women with osteopenia the CC genotype had the lowest body weight compared 
to other genotypes (p = 0.039). PvuII polymorphism and clinical parameters in the group of women with osteoporosis had 
no statistically significant correlations. 
Conclusions: The analyzed COL1A2 polymorphisms seem to be related to osteoporosis development and their particular 
clinical parameters. Hence, the COL1A2 polymorphism may be a genetic risk factor related to the development of osteoporosis. 
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INTRODUCTION
Understanding the mechanism responsible for a low 
bone mass as a main risk factor for fractures, and establish-
ing the genetic framework that determines the specific 
anatomic features of bones may help explain its role in 
the development of osteoporosis. Clinical studies, gene 
polymorphism analysis, genome-wide association studies 
(GWAS) and whole-exome sequencing, all suggest that os-
teoporosis has a strong genetic component [1].
The difficulty lies in the multifactorial character of os-
teoporotic changes because genetic factors, environmental 
factors and gene-environment interactions contribute to 
the risk of developing an osteoporotic fracture [2]. Many 
researchers and physicians try to find the most important 
polymorphic variants of selected genes that are responsible 
for bone mineral density and deterioration of bone quality.
Collagen alters in the course of bone disease and is 
involved in the pathogenesis of osteoporosis [3]. The col-
lagen network plays an important role in bone toughness 
and in age-related changes in bone quality [4]. It is observed 
that the age-related changes in bone tissue result in a de-
creased resistance to fractures, a lowered bone strength 
and flexibility, as well as an impaired functioning of colla-
gen fiber networks [5]. It has been shown that COL1A1 and 
COL1A2 candidate genes are important factors in osteopenia 
and osteoporosis development and may influence bone 
metabolism [6].
COL1A2 gene encodes the pro-alpha2 chain of type 
I collagen, which is a major component of bone extracellular 
matrix. The results of molecular genetic studies suggest that 
mutations in this gene are associated with osteogenesis 
imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, 
recessive Ehlers-Danlos syndrome classical type, idiopathic 
osteoporosis, and atypical Marfan syndrome [7].
The aim of this study is to assess the frequency of 
EcoRI, Del38 and PvuII polymorphisms of COL1A2 gene in 
the studied groups of women. Additionally, the analysis of 
relationship between the studied polymorphic variants of 
COL1A2 gene and the clinical parameters of bone turnover 
and the stage of osteoporosis development is performed.
MATERIAL AND METHODS
Study groups
This study comprises 236 unrelated Caucasian post-
menopausal women from Poland. Patients were divided 
into three subgroups given the t-score value: 90 osteoporo-
tic women (t-score ≤ –2.5, mean age: 57.55 ± 7.99 years), 
90 women with osteopenia (t-score between –2.5 and 
–1, mean age: 54.39 ± 7.76 years), and 56 healthy women 
(t-score  >  –1, mean age: 55.49 ± 8.15 years). Having been in 
menopause for at least one year was an eligibility criterion. 
The study included the clinical parameters such as: T-score, 
Z-score, weight [kg], height [cm], BMI [kg/m2], age, birth 
weight, reproductive years, age of first menstruation, age of 
last menstruation, number of pregnancies, years after meno-
pause, BMD L2–L4 [g/cm2], BMD L2–L4 YA [%] and BMD 
L2–L4 AM [%]. Bone mineral density was estimated from the 
lumbar spine L2 to L4 vertebrae using DEXA scan method 
(Dual Energy X-ray Absorptiometry). Densitometry was 
performed using the LUNAR DPX 100 camera (Lunar Corp., 
Madison, USA). The exclusion criteria include hormone re-
placement therapy and therapies that affect the bone mass 
(such as selective estrogen receptor modulators, calcitonin, 
bisphosphonates, heparin steroids, thyroid hormones, an-
tiepileptic drugs, GnRH analogue, tibolone). Other exclusion 
criteria are bilateral ovariectomy, endocrine and metabolic 
disorders, cancer and autoimmune diseases. The clinical 
data of postmenopausal women are presented in Table I.
Table 1. Characteristics of the study population (postmenopausal 
women with osteopenia, osteoporosis and normal T-score)
P Mean SEM
T-score
Osteopenia –1.831 0.043
Osteoporosis  < 0001b –3.166 0.052
Controls 0.139 0.114
Total –1.874 0.081
Z-score
Osteopenia 0.102a –0.804 0.075
Osteoporosis  < 0001b –3.032 1.847
Controls 0.644 0.175
Total –1.310 0.817
Weight [kg]
Osteopenia 0.036a 65.171 0.975
Osteoporosis 0.001b 60.208 0.943
Controls 68.723 1.432
Total 64.724 0.657
Height [cm]
Osteopenia 0.07a 162.800 0.422
Osteoporosis 0.01b 159.911 0.543
Controls 163.107 0.712
Total 161.771 0.343
BMI
Osteopenia 0.03a 24.592 0.342
Osteoporosis 0.04b 23.626 0.334
Controls 25.971 0.367
Total 24.552 0.254
Birth weight 
[g]
Osteopenia 0.046a 3216.153 75.484
Osteoporosis 0.005b 3141.250 134.081
Controls 3633.333 100.173
Total 3321.333 53.235
Reproductive 
years
Osteopenia 0.644a 36.433 0.682
Osteoporosis 0.438b 35.622 0.660
Controls 37.107 0.986
Total 36.283 0.404
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The study was approved by Local Bioethical Committee 
of Poznan University of Medical Sciences (1415/03, 158/06). 
All women were informed about the aim of conducted 
research and gave their written consent.
Detection of COL1A2 gene polymorphism  
by PCR-RFLP
The genetic analysis of COL1A2 gene polymorphism was 
conducted in the Laboratory of Experimental Pharmacoge-
netics at Chair and Department of Clinical Pharmacy and 
Biopharmacy, Poznan University of Medical Sciences. Pe-
ripheral blood samples (5 mL) were collected in tubes with 
EDTA and stored at -20°C. A commercial set QIAamp DNA 
Blood Mini Kit (Qiagen, USA) was used to isolate peripheral 
blood leukocyte DNA. To detect COL1A2 gene polymor-
phism an allele-specific PCR procedure was performed 
using the following primers: for Del: 5’- TCA GTG TAT GTT 
GCT ATC AG-3’ and 5-ATT CCA CAG TCA ACA TCA AC-3’; for 
EcoR1: 5’-GGA CTA TGA GAG TCT GTG A-3’ and 5’-TGT TTG 
ACC TGG AGT TCC AT-3’; for PvuII: 5’-GGG ATA TAA GGA TAC 
ACT AGA GG-3’ and 5’-GAA ATA TCG GCC CCG CTG GAA-3’. 
In order to examine the EcoRI and PvuII polymorphisms in 
COL1A2 gene, the restriction enzymes such as EcoR1 and 
PvuII were used. The products of PCR-RFLP reaction were 
subjected to electrophoretic separation in 2.75% agarose 
gel. The analysis of digestion products was performed by 
visualization in UV light using documentation and computer 
image analysis system UVI-KS4000/Image PC manufactured 
by Syngen Biotech Molecular Biology Instruments.
Statistical analysis was performed using SPSS 17.0 PL 
program. We used the Hardy-Weinberg equilibrium to cal-
culate the expected genotype frequency for each polymor-
phism, which was compared with the observed values using 
the chi-square test. The expected results are presented with 
95% confidence intervals (CI). We also calculated the odds ra-
tio (OR) for the genotypes and the alleles. Next, we evaluated 
the effect of the COL1A2 polymorphism on T-score, Z-score, 
L2L4AM, L2L4YA, L2L4BMD, BMI, and other clinical param-
eters. Correlation analysis between genotypes and clinical 
parameters using one-way ANOVA test was performed. 
Value of p < 0.05 was considered statistically significant.
RESULTS
The distribution of genotype frequency was consistent 
with the Hardy-Weinberg equilibrium for COL1A2 EcoRI and 
PvuII polymorphisms (Tables 2 and 3). When analyzing EcoRI 
polymorphism it was observed that the CT genotype was 
more frequent in women with osteoporosis than in women 
with normal T-score values (55.6% vs. 44.6%, OR = 2.06, CI: 
0.97-4.38, p = 0.03). In addition, the CC genotype was more 
frequent in women with normal T-score (39.3%) compared 
to women with osteoporosis (39.3% vs. 32.2%, OR = 0.73, 
CI: 0.34-1.56, p = 0.24). 
Furthermore, the analysis of COL1A2 Del38 polymor-
phism showed that the II genotype was more frequent in 
women with normal T-score values (57.1%) than in women 
with osteopenia (51.1%) or osteoporosis (46.7%). Similarly, 
the genotype DD was more frequent (14.3%) in postmeno-
pausal women with normal T-score values than in women 
with osteopenia (8.9%) or osteoporosis (6.7%) (Tables 2 and 
3). Increased OR values in heterozygotes for the Del38 pol-
ymorphism were noted in both: women with osteope-
nia (OR = 1.67, CI: 0.77-3.67, p = 0.11) and osteoporosis 
(OR = 2.18, CI: 1.02-4.79, p = 0.02).
In case of the COL1A2 PvuII polymorphism, it has been 
observed that the AC genotype was less frequent in women 
Table 1 (cont.).  Characteristics of the study population (postmenopausal 
women with osteopenia, osteoporosis and normal T-score)
P Mean SEM
Age of first 
menstruation
Osteopenia 0.536a 13.178 0.308
Osteoporosis 0.644b 13.244 0.143
Controls 13.303 0.224
Total 13.233 0.117
Age of last 
menstruation
Osteopenia 0.053a 49.688 0.588
Osteoporosis 0.068b 48.189 0.504
Controls 50.607 0.612
Total 49.334 0.326
Number of 
pregnancies
Osteopenia 0.745a 1.867 0.081
Osteoporosis 0.643b 1.922 0.225
Controls 1.964 0.140
Total 1.911 0.065
Years after 
menopause
Osteopenia 0.654a 8.600 0.769
Osteoporosis 0.001b 10.322 0.615
Controls 8.964 0.832
Total 9.343 0.309
BMD
L2-L4 [g/cm2]
Osteopenia 0.686a 0.974 0.013
Osteoporosis 0.874 b 0.817 0.012
Controls 1.221 0.021
Total 0.973 0.011
BMD 
L2-L4 YA [%]
Osteopenia 0.735a 81.144 1.532
Osteoporosis 0.682b 68.255 1.241
Controls 102.125 1.353
Total 81.207 0.743
BMD L2-L4 
AM [%]
Osteopenia 0.587a 89.544 1.717
Osteoporosis 0.568 b 78.622 1.064
Controls 110.500 1.765
Total 90.35 0.536
a — Comparison between the groups with osteopenia and normal T-score 
(one-way ANOVA) 
b — Comparison between the groups with osteoporosis and normal T-score 
(one-way ANOVA)
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with normal T-score values (37.5%) compared with women 
with osteopenia (47.8%) or osteoporosis (46.7%), while the 
CC genotype was more frequent in women with normal 
T-score values (14.3%) compared to women with osteopenia 
or osteoporosis (Tables 2 and 3).
Additionally, the genotype analysis for COL1A2 EcoRI poly-
morphism found no statistically significant correlations with 
clinical features between the women with osteopenia and the 
controls. There was a statistically insignificant tendency to-
wards higher Z-score values in women with the CC genotype 
(–7.6) for EcoRI polymorphism compared to individuals with 
the CT (–8.1) and TT (–9.1) genotypes. In case of Del28 poly-
morphism, there was a statistically significant correlation 
(p = 0.041) between lower BMI values (22.9 kg/m2) in women 
with the DD genotype compared to the ID (25.6 kg/m2) and 
the II (24.1 kg/m2) genotypes. Furthermore, the analysis of 
PvuII polymorphism showed that women with the CC geno-
type had the lowest body weight (59.6 kg) compared with 
the AC (67.5 kg) and the AA (63.8 kg) genotypes (p = 0.039). 
Furthermore, in women with osteoporosis, there were 
statistically significant correlations between polymor-
phic variants of EcoRI polymorphism of COL1A2 gene and 
Z-score values (p = 0.034). The TT genotype patients had 
the lowest Z-score values compared to other genotypes (TT: 
–2.76 vs. CT: –1.7 and CC: –1.6, p < 0.05). Other correlations 
between EcoRI polymorphism and diagnostic parameters 
were not statistically significant.
Moreover, the correlations between the Del28 poly-
morphic variants and clinical parameters in women with 
osteoporosis were also not statistically significant. However, 
a tendency was observed for lower Z-score values in patients 
with ID variant (-4.66) compared to the DD (–1.95) and the II 
(–1.56) genotypes. There was also a statistically insignificant 
correlation between the length of reproductive period and 
the distribution of genotypes for Del28 polymorphism (DD: 
39 years vs. ID: 35 years and II: 35 years). 
Also, no statistically significant correlations were observed 
for PvuII polymorphism of COL1A2 gene and clinical parame-
Table 2. Frequency of the genotype and allele of the COL1A2 EcoR1, Del38, PvuII polymorphisms in women with osteopenia and controls (Mann-
-Whitney U test)
Genotype/Allele 
Osteopenia Controls
OR 95% CI PObserved value
n (%)
Expected value
[%]
Observed value
n (%)
Expected value
[%]
EcoRI
CC 36 (40.00) 40.11 22 (39.30) 37.96 1.03 0.49–2.16 0.54
CT 42 (46.70) 46.44 25 (44.60) 47.30 1.08 0.52–2.24 0.47
TT 12 (13.30) 13.45 9 (16.10) 14.74 0.80 0.28–2.33 0.41
Total 90 (100) 100 56 (100) 100 – – –
C 114 (63.33) – 69 (61.61) – 1.07 0.64–1.80 0.43
T 66 (36.67) – 43 (38.39) – 0.93 0.55–1.56 0.43
Total 180 (100) – 112 (100) – – – –
Del38
II 46 (51.10) 50.57 32 (57.14) 51.02 0.78 0.37–1.62 0.29
ID 36 (40.00) 41.09 16 (28.58) 40.82 1.67 0.77–3.67 0.11
ID 8 (8.90) 8.34 8 (14.28) 8.16 0.58 0.17–1.92 0.23
Total 90 (100) 100 56 (100) 100 – – –
I 128 (71.11) – 80 (71.43) – 0.98 0.56–1.71 0.53
D 52 (28.89) – 32 (28.57) – 1.01 0.58–1.78 0.53
Total 180 (100) – 112 (100) – – – –
PvuII
AA 38 (42.20) 43.71 27 (48.20) 44.84 0.78 0.25–2.15 0.29
AC 43 (47.80) 44.81 21 (37.50) 44.24 1.52 0.73–3.20 0.14
CC 9 (10.00) 11.48 8 (14.30) 10.92 0.67 0.21–2.14 0.29
Total 90 (100) 100 56 (100) 100 – – –
A 119 (66.11) – 75 (66.96) – 0.96 0.56–1.63 0.49
C 66 (33.89) – 37 (33.04) – 1.04 0.61–1.77 0.49
Total 180 (100) – 112 (100) – – – –
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ters in the group of women with osteoporosis. Analysis showed 
a tendency towards lower Z-score values in women with the 
AA genotype compared to other genotypes (AA: –4.71 vs. AC: 
–1.56 and CC: –1.67). The highest birth weight was noted in 
women with the CC genotype (CC: 3400 g vs. AC: 3197 g and 
AA: 2978 g). Moreover, the longest reproductive period was 
observed in women with the CC genotype (38 years) compared 
to patients with AC and AA genotypes (35 years).
DISCUSSION
The analysis of polymorphic variability of protein coding 
genes, which take part in the processes of bone turnover and 
in the stabilization of the skeletal system is an important as-
pect of research concerning osteoporosis and bone disease. 
Many polymorphic sequence variants in the type I collagen 
gene (COL1A1 and COL1A2) has been found and described 
so far [8, 9]. Additionally, researchers have described the 
implication that the variants’ have in changes of the skeletal 
system and in the development of osteogenesis imperfecta 
or osteoporosis [6, 7, 10].
In this study we have analyzed the relationship between 
the EcoRI, PvuII and Del38 polymorphism of COL1A2 gene 
and clinical and bone parameters, as well as we have esti-
mated the incidence rate of osteoporosis.
In case of the EcoRI polymorphism we have shown 
a relationship between heterozygous TC, homozygous TT 
variants, decreased bone mineral density and the develop-
ment of osteoporosis. The results obtained by our research 
team were consistent with the Hardy–Weinberg equilibrium 
but were not statistically significant. However, statistically 
significant correlation for this polymorphism was obtained 
for pregnancy-related clinical parameters. The observed 
decreased bone mass in the carriers of T allele may suggest 
its correlation with the development of osteoporosis, which 
requires a statistically significant confirmation on a larger 
study group. So far, very few studies were performed in 
the field of influence of EcoR1 of the COL1A2 gene on the 
creation of bone mass in postmenopausal women leaving 
its influence on the bone mass not confirmed [11]. This 
polymorphism was analyzed intensively and was used as 
Table 3. Frequency of the genotype and allele of the COL1A2 EcoR1, Del38, PvuII polymorphisms in women with osteoporosis and controls
Genotype/Allele 
Osteoporosis Controls
OR 95% CI PObserved value
n (%)
Expected value
[%]
Observed value
n (%)
Expected value
[%]
EcoRI
CC 29 (32.20) 36.00 22 (39.30) 37.96 0.73 0.34–1.56 0.24
CT 50 (55.60) 48.00 25 (44.60) 47.30 2.06 0.97–4.38 0.03
TT 11 (12.20) 16.00 9 (16.10) 14.74 0.72 0.25–2.15 0.33
Total 90 (100) 100 56 (100) 100 – – –
C 108 (60.00) – 69 (61.61) – 0.94 0.56–1.56 0.44
T 72 (40.00) – 43 (38.39) – 1.07 0.64–1.79 0.44
Total 180 (100) – 112 (100) – – – –
Del38
II 42 (46.70) 49.00 32 (57.14) 51.02 0.65 0.32–1.35 0.14
ID 42 (46.70) 42.00 16 (28.57) 40.82 2.18 1.02–4.79 0.02
ID 6 (6.60) 9.00 8 (14.28) 8.16 0.42 0.12–1.51 0.11
Total 90 (100) 100 56 (100) 100 – – –
I 126 (70.00) – 80 (71.43) – 0.93 0.53–1.62 0.45
D 54 (30.00) – 32 (28.57) – 1.07 0.62–1.87 0.45
Total 180 (100) – 112 (100) – – – –
PvuII
AA 42 (46.70) 48.00 27 (48.20) 44.84 0.94 0.45–1.94 0.49
AC 42 (46.70) 42.00 21 (37.50) 44.24 1.45 0.70–3.06 0.18
CC 6 (6.60) 9.00 8 (14.30) 10.92 0.43 0.11–1.51 0.11
Total 90 (100) 100 56 (100) 100 – – –
A 126 (70.00) – 75 (66.96) – 1.15 0.67–1.96 0.33
C 54 (30.00) – 37 (33.04) – 0.87 0.51–1.49 0.33
Total 180 (100) – 112 (100) – – – –
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an anthropogenic marker in the search for ethnicity-based 
inter-population variance. Pepe et al. have used genotyp-
ing of COL1A2 with EcoRI enzyme to differentiate ethnically 
American population living in Cayapa region: the indig-
enous from the Asian descendants [12]. In a later study, 
same authors have differentiated ethnically four West Af-
rican and two Asian populations [13]. As a result, it was 
shown that EcoR1 polymorphism of the COL1A2 gene was 
a highly distinctive population marker making it possible 
to differentiate ethnically human populations. Population 
analysis based on this polymorphism was used to differ-
entiate human populations in Asia, Africa and America by 
other researchers as well [14, 15, 16]. In case of Europeans 
in contrast, the analyses based on EcoRI polymorphism, 
among others, has shown a high genetic homogeneity [17]. 
Our study on the influence of EcoRI polymorphism of the 
COL1A2 gene on the osteoporotic changes is one of the first 
studies on its relationship with osteoporosis. 
Mechanisms underlying the influence of individual PvuII 
polymorphic sequence variants in the COL1A2 gene on the 
risk of fractures remain unknown. Changes in the sequence 
from CpA to CpC described as a transversion in exon 25 had no 
effect on the coding of the rest of proline in position 392 but 
a relationship has been found between this polymorphism 
and osteogenesis imperfecta or osteoporosis [18, 19]. The 
analysis of PvuII polymorphism carried out by our research 
team showed that the AA (PP) genotype was correlated in 
a statistically significant way with a lower value of Z-score 
in women with osteoporosis and with lower birth weight of 
these women. Numerous studies have shown that a lower 
birth weight was associated with a predisposition to many 
diseases in the adult life, e.g. hypertension, insulin resistance, 
ischemia and lowered bone mass [20-23]. AA (PP) homozy-
gotes were also evident to have a shorter reproduction period. 
That must have led to negative changes in hormonal balance 
and in skeletal system in the carriers, since a long reproductive 
period is known to have a protective factor in osteoporosis de-
velopment [24]. These observations were confirmed in a study 
carried out on a population of adolescent females. Girls with 
PP genotype had a 4.9-fold higher relative risk of fracture 
than girls with pp (CC) genotype (p = 0.015) [25]. 
The study on the Del38 polymorphism presented in this 
paper and the search for a relationship between individual 
polymorphic variants, bone mass and incidence of osteo-
porosis fills a gap in the literature, since available studies 
concentrate on this polymorphism mainly in light of popula-
tion biomarker or liver cancer development [26, 27]. In our 
study we have observed that genotype II was more common 
in healthy women as opposed to DD genotype, which was 
associated with osteopenia and osteoporosis. It has to be 
emphasized that our search for association between the 
development of osteoporosis and Del38 polymorphism, 
whether in Polish, European or world population, is one of 
the very first of its kind. 
CONCLUSIONS
In our study we report some significant associations 
between the EcoRI, PvuII and Del38 polymorphisms of CO-
L1A2 gene and clinical and bone parameters together with 
the incidence rate of osteoporosis. 
Based on the presented data, it is probable that the 
COL1A2 polymorphism has a positive association with os-
teoporosis development. We conclude that the relationship 
between the studied COL1A2 polymorphisms and clinical and 
bone parameters with incidence rate of osteoporosis requires 
a statistically significant confirmation on a larger study group.
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